1921
Volume 90, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We studied cross-reactive antibodies against avian influenza H5N1 and 2009 pandemic (p) H1N1 in 200 serum samples from US military personnel collected before the H1N1 pandemic. Assays used to measure antibodies against viral proteins involved in protection included a hemagglutination inhibition (HI) assay and a neuraminidase inhibition (NI) assay. Viral neutralization by antibodies against avian influenza H5N1 and 2009 pH1N1 was assessed by influenza (H5) pseudotyped lentiviral particle-based and H1N1 microneutralization assays. Some US military personnel had cross-neutralizing antibodies against H5N1 (14%) and 2009 pH1N1 (16.5%). The odds of having cross-neutralizing antibodies against 2009 pH1N1 were 4.4 times higher in subjects receiving more than five inactivated whole influenza virus vaccinations than those subjects with no record of vaccination. Although unclear if the result of prior vaccination or disease exposure, these pre-existing antibodies may prevent or reduce disease severity.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0151
2014-01-08
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/90/1/149.html?itemId=/content/journals/10.4269/ajtmh.13-0151&mimeType=html&fmt=ahah

References

  1. Rubertone MV, Brundage JF, , 2002. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 92: 19001904.[Crossref]
  2. Lee MS, Yang CF, , 2003. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains. J Infect Dis 188: 13621366.[Crossref]
  3. Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD, , 2004. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain. Pediatr Infect Dis J 23: 10531055.[Crossref]
  4. Lambre CR, Terzidis H, Greffard A, Webster RG, , 1990. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 135: 4957.[Crossref]
  5. Garcia JM, Lagarde N, Ma ES, de Jong MD, Peiris JS, , 2010. Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay. J Clin Virol 47: 2933.[Crossref]
  6. Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ, , 2010. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2: 2524.[Crossref]
  7. Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, Vest KG, Russell KL, DeFraites RF, Sanchez JL, , 2010. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.[Crossref]
  8. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM, , 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 19451952.[Crossref]
  9. Tang JW, Tambyah PA, Wilder-Smith A, Puong KY, Shaw R, Barr IG, Chan KP, , 2010. Crosss-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore. Emerg Infect Dis 16: 874876.[Crossref]
  10. Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, de Jong MD, Farrar J, Riley S, Smith GJ, Guan Y, , 2009. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 15: 18491850.[Crossref]
  11. Grabenstein JD, Pittman PR, Greenwood JT, Engler RJ, , 2006. Immunization to protect the US Armed Forces: heritage, current practice, and prospects. Epidemiol Rev 28: 326.[Crossref]
  12. Murphy BR, Kasel JA, Chanock RM, , 1972. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286: 13291332.[Crossref]
  13. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ, , 2007. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4: e59.[Crossref]
  14. Smallman-Raynor M, Cliff AD, , 2007. Avian influenza A (H5N1) age distribution in humans. Emerg Infect Dis 13: 510512.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0151
Loading
/content/journals/10.4269/ajtmh.13-0151
Loading

Data & Media loading...

  • Received : 22 Mar 2013
  • Accepted : 21 Jul 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error